Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sugandha Dandekar"'
Autor:
Sugandha Dandekar, Hemani Wijesuriya, Tim Geiger, David Hamm, Gary W. Mathern, Geoffrey C. Owens
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Rasmussen encephalitis (RE) is a rare pediatric neuroinflammatory disease characterized by intractable seizures and unilateral brain atrophy. T cell infiltrates in affected brain tissue, and the presence of circulating autoantibodies in some RE patie
Externí odkaz:
https://doaj.org/article/6e84615661dc4a71a1d3cf083fa683cf
Autor:
Gottfried E. Konecny, Dennis J. Slamon, Gerrit Los, Fritz Jänicke, Nitin Udar, Sugandha Dandekar, Hong-Mei Rong, Natarajan Venkatesan, Victor E. Velculescu, Siân Jones, Boris Winterhoff, Alexandra Meuter, Charles Ginther, Lee Anderson, Judy Dering, Meenal Chalukya, Kanthinh Manivong, Jing Wei Qi, Teodora Kolarova, Christine zu Eulenburg, Maike Ihnen
PDF file - 603K, Supplemental Figure S1: Gene maps of the BRCA1 (A) and BRCA2 (B) CpG islands examined with bisulfite pyrosequencing. Supplemental Figure S2: Anchorage independent growth inhibition at 1μM rucaparib in soft agar. Of the 39 tested ova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df54f80fb3880b007f62b7f6bbc31c4
https://doi.org/10.1158/1535-7163.22500252
https://doi.org/10.1158/1535-7163.22500252
Autor:
Gottfried E. Konecny, Dennis J. Slamon, Gerrit Los, Fritz Jänicke, Nitin Udar, Sugandha Dandekar, Hong-Mei Rong, Natarajan Venkatesan, Victor E. Velculescu, Siân Jones, Boris Winterhoff, Alexandra Meuter, Charles Ginther, Lee Anderson, Judy Dering, Meenal Chalukya, Kanthinh Manivong, Jing Wei Qi, Teodora Kolarova, Christine zu Eulenburg, Maike Ihnen
Here, we investigate the potential role of the PARP inhibitor rucaparib (CO-338, formerly known as AG014699 and PF-01367338) for the treatment of sporadic ovarian cancer. We studied the growth inhibitory effects of rucaparib in a panel of 39 ovarian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbeee4da3ffc16ade9b2433aa2b60aae
https://doi.org/10.1158/1535-7163.c.6536409.v1
https://doi.org/10.1158/1535-7163.c.6536409.v1
Autor:
Gottfried E. Konecny, Dennis J. Slamon, Gerrit Los, Fritz Jänicke, Nitin Udar, Sugandha Dandekar, Hong-Mei Rong, Natarajan Venkatesan, Victor E. Velculescu, Siân Jones, Boris Winterhoff, Alexandra Meuter, Charles Ginther, Lee Anderson, Judy Dering, Meenal Chalukya, Kanthinh Manivong, Jing Wei Qi, Teodora Kolarova, Christine zu Eulenburg, Maike Ihnen
PDF file - 66K, Cell lines and culture media.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10249e54d733f8ff8e4066b47d2df516
https://doi.org/10.1158/1535-7163.22500249.v1
https://doi.org/10.1158/1535-7163.22500249.v1
Autor:
Ilse H Stalis, Jeanette C. Papp, Cynthia C. Steiner, Steven M. Thomas, Lindsay C. Sidak-Loftis, Sugandha Dandekar, Jessica Martin Judson, Leona G. Chemnick, Michael N Romanov, Kelli Walker, Michael Mace, Oliver A. Ryder
Publikováno v:
Journal of Heredity
Parthenogenesis is a relatively rare event in birds, documented in unfertilized eggs from columbid, galliform, and passerine females with no access to males. In the critically endangered California condor, parentage analysis conducted utilizing polym
Autor:
Oliver A Ryder, Steven Thomas, Jessica Martin Judson, Michael N Romanov, Sugandha Dandekar, Jeanette C Papp, Lindsay C Sidak-Loftis, Kelli Walker, Ilse H Stalis, Michael Mace, Cynthia C Steiner, Leona G Chemnick
This is a correction to: Journal of Heredity, Volume 112, Issue 7, October 2021, Pages 569–574, https://doi.org/10.1093/jhered/esab052\ud \ud In the originally published version of this article there were errors within an author’s affiliations. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8316b2ac9718bdbe702647b940da3d4f
https://kar.kent.ac.uk/92565/1/Ryder&al2021(Corrigendum_to_Facultative_Parthenogenesis_in_Cal).pdf
https://kar.kent.ac.uk/92565/1/Ryder&al2021(Corrigendum_to_Facultative_Parthenogenesis_in_Cal).pdf
Autor:
Otoniel Martinez-Maza, Sudhir Penugonda, Dharma R. Thapa, Sugandha Dandekar, Po Yin Chang, Jeremy J. Martinson, Roger Detels, Shen Chih Chang, Priya Duggal, Erin C. Peckham-Gregory, Zuo-Feng Zhang, Jay H. Bream, Shehnaz K. Hussain
Publikováno v:
Cancer Epidemiology. 45:47-57
Background MicroRNAs, small non-coding RNAs involved in gene regulation, are implicated in lymphomagenesis. We evaluated whether genetic variations in microRNA coding regions, binding sites, or biogenesis genes (collectively referred to as miRNA-SNPs
Autor:
Armen K. Goenjian, Ernest P. Noble, Sofia T. Stepanyan, Julia N. Bailey, David P. Walling, Alan M. Steinberg, Sugandha Dandekar
Publikováno v:
Journal of Affective Disorders. 172:472-478
Dopaminergic and serotonergic systems have been implicated in PTSD. The present study evaluated the association of four catechol-O-methyltransferase (COMT) gene loci, and the joint effect of COMT and tryptophan hydroxylase 2 (TPH2) genes on PTSD symp
Autor:
David Hamm, Hemani Wijesuriya, Sugandha Dandekar, Gary W. Mathern, Geoffrey C. Owens, Tim Geiger
Publikováno v:
Frontiers in immunology, vol 7, iss DEC
Frontiers in Immunology
Frontiers in Immunology, Vol 7 (2016)
Frontiers in Immunology
Frontiers in Immunology, Vol 7 (2016)
Rasmussen encephalitis (RE) is a rare pediatric neuroinflammatory disease characterized by intractable seizures and unilateral brain atrophy. T cell infiltrates in affected brain tissue and the presence of circulating autoantibodies in some RE patien
Autor:
Meenal Chalukya, Boris Winterhoff, Siân Jones, Nitin Udar, Teodora Kolarova, Fritz Jänicke, Gerrit Los, Dennis J. Slamon, Sugandha Dandekar, Gottfried E. Konecny, Hong Mei Rong, Victor E. Velculescu, Christine Eulenburg, Judy Dering, Maike Ihnen, Natarajan Venkatesan, Alexandra Meuter, Kanthinh Manivong, Charles Ginther, Jing Wei Qi, Lee Anderson
Publikováno v:
Molecular Cancer Therapeutics. 12:1002-1015
Here, we investigate the potential role of the PARP inhibitor rucaparib (CO-338, formerly known as AG014699 and PF-01367338) for the treatment of sporadic ovarian cancer. We studied the growth inhibitory effects of rucaparib in a panel of 39 ovarian